๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-05-26

Assessment of Combined CCM and ICD Device in HFrEF (NCT05855135)

Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects With Heart Failure and Reduced Ejection Fraction

๐Ÿ”ต Active, Not Recruiting Observational / Diagnostic โš™๏ธ Medical Device Protocol Sponsor: Impulse Dynamics

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The goal of this clinical trial is to demonstrate that the OPTIMIZERยฎ Integra CCM-D System (the "CCM-D System") can safely and effective convert induced ventricular fibrillation (VF) and spontaneous ventricular tachycardia and/or ventricular fibrillation (VT/VF) episodes in subjects with Stage C or D heart failure who remain symptomatic despite being on guideline-directed medical therapy (GDMT), are not indicated for cardiac resynchronization therapy (CRT), and have heart failure with reduced left ventricular ejection fraction (LVEF โ‰ค40%). Eligible subjects will be implanted with the CCM-D System. A subset of subjects will be induced into ventricular fibrillation "on the table" in the implant procedure room. During the follow-up period, inappropriate shock rate and device-related complications will be evaluated. The follow-up period is expected to last at least two years.

Who can join: Review the eligibility criteria below.

Location: Phoenix Heart โ€” Glendale, Arizona

Age range: 18 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (59 Sites)

Showing the first 25 of 59 sites.

  • Phoenix Heart โ€” Glendale, Arizona
  • CardioVascular Associates of Mesa โ€” Mesa, Arizona
  • Southwest Cardiovascular Associates โ€” Mesa, Arizona
  • Arizona Heart Rhythm โ€” Phoenix, Arizona
  • CVC Cardiovascular Consultants โ€” Phoenix, Arizona
  • Phoenix Heart โ€” Phoenix, Arizona
  • Honor Health โ€” Scottsdale, Arizona
  • University of Southern California โ€” Los Angeles, California
  • Cedars Sinai Medical Center โ€” Los Angeles, California
  • Hartford HealthCare โ€” Hartford, Connecticut
  • Broward Health Medical Center โ€” Fort Lauderdale, Florida
  • Baptist Health South Florida โ€” Miami, Florida
  • Mount Sinai Medical Center Miami Beach โ€” Miami Beach, Florida
  • Advent Health Orlando โ€” Orlando, Florida
  • Iowa Heart Center โ€” West Des Moines, Iowa
  • University of Kansas Medical Center โ€” Kansas City, Kansas
  • Baptist Health Lexington โ€” Lexington, Kentucky
  • Massachusetts General Hospital โ€” Boston, Massachusetts
  • Saint Luke's Hospital โ€” Kansas City, Missouri
  • St. Louis VA โ€” St Louis, Missouri
  • St. Louis Heart and Vascular โ€” St Louis, Missouri
  • Deborah Heart and Lung Center โ€” Browns Mills, New Jersey
  • Virtua โ€” Cherry Hill, New Jersey
  • Hackensack University Medical Center โ€” Hackensack, New Jersey
  • The Heart House - Cardiovascular Associates of the Delaware Valley โ€” Haddon Heights, New Jersey

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Heart Failure clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—